Multidimensional instruments with an integral approach to identify frailty in community-dwelling people: protocol for a systematic psychometricreview by Zamora-Sánchez, Juan-José et al.
1Zamora- Sánchez JJ, et al. BMJ Open 2019;9:e033160. doi:10.1136/bmjopen-2019-033160
Open access 
Multidimensional instruments with an 
integral approach to identify frailty in 
community- dwelling people: protocol 
for a systematic psychometric review
Juan José Zamora- Sánchez   ,1 Vicente Gea- Caballero,2 Iván Julián- Rochina,3 
Lina Jódar- Fernández,1 Iris Lumillo- Gutiérrez,1 Meritxell Sastre- Rus,4 
Ana- María Urpí-Fernández,1 Edurne Zabaleta- del- Olmo   5
To cite: Zamora- 
Sánchez JJ, Gea- Caballero V, 
Julián- Rochina I, et al.  
Multidimensional instruments 
with an integral approach to 
identify frailty in community- 
dwelling people: protocol for 
a systematic psychometric 
review. BMJ Open 
2019;9:e033160. doi:10.1136/
bmjopen-2019-033160
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
033160).
Received 23 July 2019
Revised 18 November 2019
Accepted 18 November 2019
1Institut Català de la Salut, 
Barcelona, Spain
2Escuela Universitaria de 
Enfermería La Fe, Valencia, 
Spain
3Universitat de València, 
Valencia, Spain
4Escola Universitària 
d'Infermeria Gimbernat i Tomàs 
Cerdà, Barcelona, Spain
5Institut de Recerca en Atenció 
Primària Jordi Gol, Barcelona, 
Spain
Correspondence to
Juan José Zamora- Sánchez;  
 jjzamora. bcn. ics@ gencat. cat
Protocol
© Author(s) (or their 
employer(s)) 2019. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
Strengths and limitations of this study
 ► The review will be carried out using the best prac-
tices in psychometric reviews (consensus- based 
standards for the selection of health measurement 
instruments guidelines).
 ► A comprehensive literature search strategy has 
been planned.
 ► We will not use language restrictions in the search 
strategy.
 ► In this review, measurement properties, interpret-
ability and feasibility of the measurement instru-
ments will be assessed.
 ► This work will be helpful to identify the most valid, 
time- effective and easy- to- use frailty assessment 
instruments in community- dwelling people.
AbStrACt
Introduction An increasing number of investigations 
highlight the complex nature of frailty; therefore, the 
use of multidimensional assessment instruments could 
be useful in clinical decision- making. Frail people 
are found mainly in the community setting which is 
why this is the ideal environment for early screening 
and intervention. For this purpose, it is necessary 
to have valid, time- effective and easy- to- use frailty 
assessment instruments. The aim of this review is to 
critically appraise, compare and summarise the quality 
of the measurement properties of all multidimensional 
instruments with an integral approach to identify frailty 
in community- dwelling people.
Methods and analysis Medline, Psychological 
Information Database (PsycINFO) and Cumulative Index 
to Nursing and Allied Health Literature (CINAHL) will 
be searched from their inception dates. We will also 
conduct searches in databases of grey literature. No 
limits will be applied for language. A highly sensitive 
validated search filter will be used for finding studies 
on measurement properties. An additional search 
including the names of the instruments found in the 
initial search will also be undertaken. Studies aiming 
at the development of a measurement instrument, the 
evaluation of one or more measurement properties or 
the evaluation of its interpretability will be included. 
The instrument should have an integral approach 
(physical, psychological and social) and it should 
measure all three domains. The context of use should 
be a community setting. Two reviewers independently 
will screen the references and assess the risk of bias 
by consensus- based standards for the selection of 
health measurement instruments checklist. To assess 
the overall evidence for the measurement properties of 
the identified instruments, the results of the different 
studies, adjusted for their methodological quality, will be 
combined.
Ethics and dissemination Ethical approval and patient 
consent are not required as this is a psychometric 
review based on published studies. The results of 
this review will be disseminated at conferences and 
published in an international peer- reviewed journal.
PrOSPErO registration number CRD42019120212.
IntrOduCtIOn
Global ageing is contributing to an increase 
in the number of people with multimorbidity 
and complex care needs.1 In this regard, the 
application of the concept of frailty can be 
useful in order to deal with these problems. 
People in fragile state have a loss of func-
tional reserve and an increase in vulnera-
bility to stressors. Frailty is associated with 
several important adverse health outcomes 
such as increase in disability and in mortality, 
falls, institutionalisation, hospitalisation, 
lower quality of life and a greater use of 
healthcare.2–5
Frailty is potentially preventable and strat-
egies to prevent and stop its progression 
are essential. A great amount of research 
has been carried out in order to identify 
who can benefit from these strategies, most 
of it focusing on the development of frailty 
measurements to objectively quantify this 
concept.6–9 Nevertheless, the concept of 
frailty is in constant evolution and there is 
a wide debate and lack of agreement on its 
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conceptual and operational definition, so there is broad 
variability with respect to the conceptual frameworks and 
theoretical perspectives of these instruments.6 7 10
The two most commonly used frailty measurements are 
Fried’s frailty phenotype11 and Rockwood and Mitnits-
ki’s Frailty Index.12 Fried’s frailty phenotype is based on 
the physical characteristics of frailty by considering a 
person as frail if he/she presents three or more of the 
following criteria: unintentional weight loss, weakness, 
exhaustion, slowness and low physical activity. This frailty 
measurement has a unidimensional approach and does 
not include psychosocial components although there is 
broad consensus in the debate regarding the multidi-
mensional nature of frailty, with physical and psychoso-
cial factors involved in its development.7 10 13–15 Likewise, 
if frailty is measured only in terms of physical losses, there 
is the danger of carrying out prevention and manage-
ment strategies focused solely on these aspects.10 The 
Rockwood and Mitnitski’s Frailty Index is based on 
biological causative theory and involves the accumula-
tion of 30 or more comorbidities, symptoms, diseases, 
disabilities or any health deficiency.12 Its rationale points 
out that the greater the number of health deficits, the 
higher the frailty.16 This index incorporates the multi-
dimensional nature of frailty, but its calculation can be 
time consuming so it is not popular among clinicians.6 17 
Moreover, given the complex nature of frailty and in the 
absence of a consensual definition, the components of 
frailty vary considerably between the different measure-
ment instruments.18 Frailty, disability for activities of 
daily living and multimorbidity are overlapped but there 
is some agreement that these concepts should be sepa-
rated.14 19 Disability for activities of daily living should 
be seen as an adverse outcome of frailty and multimor-
bidity as an antecedent.14 For this reason, it is suggested 
that these components should be approached separately, 
since on one hand they are related, on the other their 
management is different and considering them as frailty 
components may confuse the interventions designed to 
prevent and mitigate frailty.6 7 14 18
Frail people are found mainly in the community 
setting which is why this is the ideal environment for 
early screening and intervention.20 21 These early activi-
ties can help prevent, decrease and delay adverse health 
consequences for people and their families or caregivers. 
Healthcare in this setting should be integral, consid-
ering the physical, psychosocial and environmental 
aspects.7 Therefore, multidimensional instruments with 
an integral and community- based approach may be more 
useful than those based on acute care for this preventive 
purpose. However, most of these instruments have been 
evaluated from the perspective of their predictive value 
of adverse outcomes, and evaluation of their suitability as 
tools for clinical decision- making and as an intervention 
target is scarce.22 Furthermore, measurement proper-
ties of an instrument may be affected by the measure-
ment setting, so an instrument suitable for a context of 
use might not be valid for another.23 On the other hand, 
frailty identification in community- dwelling people can 
involve a resource- intensive process. That is why, clini-
cians, mostly family physicians and community nurses, 
express the need for time- effective and easy- to- use instru-
ments as well as valid and reliable frailty assessment.24 25 
That is why, it is necessary to identify which are the most 
suitable instruments for community care.
An umbrella review of frailty screening tools26 identi-
fies three reviews which included community- dwelling 
people.27–29 There are also systematic reviews focused 
on primary care or public health settings.9 30–32 However, 
none of these reviews use a specific methodology for 
systematic psychometric reviews of measurement instru-
ments. Likewise, some of these reviews are mainly focused 
on the use of the instruments and not on their quality.27 31 
Besides, these reviews are not aimed at identifying frailty 
measurement instruments based on a multidimensional 
and integral conceptual model. In addition, comprehen-
sive methodological guideline for systematic reviews of 
measurement instruments has recently been developed 
by the Consensus- based Standards for the selection of 
health Measurement INstruments (COSMIN).33–35 The 
use of this guideline allows selecting the best measure-
ment instrument in a methodologically sound way.
For all these reasons, we plan to carry out a systematic 
psychometric review on multidimensional instruments to 
identify frailty in community- dwelling people according 
to COSMIN methodology. The aim of this review is to 
critically appraise, compare and summarise the quality 
of the measurement properties of all multidimensional 
instruments with an integral approach to identify frailty 
in community- dwelling people. We will seek to answer 
the following question: What are the most suitable multi-
dimensional measurement instruments with an integral 
approach to identify frailty among community- dwelling 
people?
MEthOdS And AnAlySIS
We will perform a systematic psychometric review 
according to the procedure proposed by COSMIN initia-
tive.33–35 The review protocol adheres to the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols (PRISMA- P) statement.36
Eligibility criteria
We will apply the following eligibility criteria.
Study designs
The study should be aimed at developing a measurement 
instrument, evaluating one or more measurement prop-
erties or its interpretability and feasibility. We will exclude 
studies that only use the measurement instrument as 
an outcome measurement instrument (eg, randomised 
controlled trials) or studies in which the instrument is 
used in a validation study of another instrument. Like-
wise, as recommended by COSMIN guidelines, we will 
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box 1 draft Medline (via PubMed) search strategy
1. “Frailty”[(MH]) OR “Frail Elderly”[(MH])
2. Frail*
3. #1 OR #2
4. “Primary Health Care”[(MH]) OR “Ambulatory Care”[(MH]) OR 
“Outpatients”[(MH]) OR “Home Care Services”[(MH]) OR “Nursing 
Homes”[(MH]) OR “Homes for the Aged”[(MH]) OR “Home Care 
Services”[(MH]).
5. “Primary care” OR “Primary Health care” OR “Primary Healthcare” 
OR “Ambulatory care” OR outpatient* OR “community- dwelling” OR 
“community dwelling” OR community OR home* OR resident* OR 
domestic OR domiciliary.
6. #4 OR #5
7. “Filter for measurement properties” by Terwee et al.37
8. #3 AND #6 AND #7
exclude congress abstracts because often very limited 
information on the design of the study is found in them.
Construct of interest
The instrument should have an integral approach 
according to the following definition of frailty: ‘a dynamic 
state affecting an individual who experiences losses in one 
or more domains of human functioning (physical, psycho-
logical or social), which is caused by the influence of a 
range of variables and which increases the risk of adverse 
outcomes’.14 We will select only instruments which include 
measurements of all three domains: physical domain 
(nutrition, mobility, physical activity, strength, endur-
ance, balance, sensory functions), psychological domain 
(cognition, mood and coping) and social domain (social 
relations and social support). This eligibility criterion is 
based on the need to provide care focuses on the whole 
person since focusing on a single domain can lead to frag-
mentation of care.10 Likewise, if frailty is measured in only 
one domain, there is a danger of carrying out prevention 
and management strategies focused on a single domain. 
Moreover, if only one domain is measured, there is a 
risk that frail people will not be identified because the 
domains not evaluated could be affected.
Study sample
The study sample should represent community- dwelling 
people (at least 50% of the sample) of any age (in order 
to identify the most age- appropriate instruments).
Context of use
The measurement setting should be a community setting, 
for instance, adult day care centres, home or primary 
healthcare centres.
Information sources
We will perform a comprehensive literature search in 
Medline (via PubMed), Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) (via Elton 
Bryson Stephens Company (EBSCO)) and Psychological 
Information Database (PsycINFO). We will also conduct 
searches in the databases of grey literature (OpenGrey 
and Grey Literature Report). Databases will be searched 
from their inception and language restrictions will not be 
applied. We will not use language restrictions in the search 
strategy. Reviewers are proficient in English, French 
and Spanish; if any selected article is written in other 
languages, they will have financial resources to translate 
it. We will check the reference lists of included studies 
and used citation tracking resources in order to identify 
additional relevant studies. Finally, we will perform an 
additional search including the names of the instruments 
which are found in the initial search.
Search strategy
The search will contain search terms related to the 
following aspects: (1) construct of interest: frailty; (2) 
target population: community- dwelling people; (3) 
measurement properties: a highly sensitive validated 
search filter for finding relevant studies on measurement 
properties.37 A draft Medline (via PubMed) strategy is 
described in box 1.
Select abstracts and full-text articles
Literature search results will be uploaded to Rayyan QCRI, 
a free web application that helps collaboration among 
reviewers during study selection process.38 Reviewers will 
independently screen the titles and abstracts yielded by 
the search against the eligibility criteria. Full- text article 
for all records that will meet the eligibility criteria or 
where there is any doubt will be obtained. Subsequently, 
two reviewers will screen the full- text articles and decide 
which of them meet the eligibility criteria. If necessary, 
we will contact the authors to resolve doubts about eligi-
bility. Differences will be resolved by discussion and if 
consensus between the two reviewers cannot be reached, 
a third reviewer will be consulted. We will record the 
reasons for exclusion.
Evaluate the measurement properties
The methodological quality of every single study on 
a measurement property will be assessed using the 
COSMIN risk of bias checklist.33 This checklist has 10 
boxes to assess the following measurement properties: 
(1) instrument development; (2) content validity; (3) 
structural validity; (4) internal consistency; (5) cross- 
cultural validity/measurement invariance: (6) reliability; 
(7) measurement error; (8) criterion validity; (9) hypoth-
eses testing for construct validity and (10) responsiveness. 
Reviewers will determine which measurement properties 
are assessed in each article and each measurement prop-
erty will be assessed separately, using the corresponding 
COSMIN box. Each measurement property will be rated 
as very good, adequate, doubtful or inadequate quality. 
Subsequently, the result of each study on each measure-
ment property will be rated against the criteria for good 
measurement properties,39 40 and each result will be rated 
as either sufficient (+), insufficient (−) or indeterminate 
(?). We will use the Excel file provided on the COSMIN 
website for data entry and we will calculate overall ratings 
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(https:// cosmin. nl/ wp- content/ uploads/ Scoring- form- 
COSMIN- boxes_ april_ final. xlsx). These judgements 
will be made independently by two review authors. Any 
disagreement will be resolved by discussion and if it is 
not resolved, a third reviewer will be consulted. Data 
extraction will be done by two reviewers independently 
and we will use the overview tables available on COSMIN 
website (https:// cosmin. nl/ wp- content/ uploads/ Empty- 
tables. docx).
describe interpretability and feasibility
We will also extract data on the characteristics of the 
instrument (characteristics of the included samples and 
results on the measurement properties) and on infor-
mation about interpretability and feasibility of its scores 
(distribution of scores, floor and ceiling effects, purpose 
and context of use, completion time, cost, length, type 
and ease administration, and so on). This information 
will be used to decide if the different studies are suffi-
ciently similar to be pooled or qualitatively summarised.
data synthesis and confidence in cumulative evidence
If the results of all available studies per measurement prop-
erty are consistent, the results of studies will be quantita-
tively pooled or qualitatively summarised, and compared 
against the criteria for good measurement properties. 
The quality of evidence will be graded using a modi-
fied Grading of Recommendations Assessment, Devel-
opment, and Evaluation approach as a high, moderate, 
low and very low evidence.34 If the results are inconsis-
tent, we will use several strategies: (1) find explanations 
and summarise per subgroup, (2) do not summarise the 
results and do not grade the evidence, or (3) base the 
conclusion on the majority on consistent results, and 
downgrade for inconsistency.
Formulate recommendations
Finally, we will formulate recommendations on the most 
suitable instruments34 40 into three categories:
A. measurement instrument with evidence for sufficient 
content validity and at least low- quality evidence for 
sufficient internal consistency. This instrument can be 
recommended for use and results obtained with this 
instrument can be trusted.
B. Measurement instrument categorised not in A or C. 
This instrument has potential to be recommended for 
use, but it requires further research to assess its quality.
C. Measurement instrument with high- quality evidence 
for an insufficient measurement property. This instru-
ment should not be recommended for use.
These recommendations will be based on the evalua-
tion of the measurement properties and on interpreta-
bility and feasibility aspects.
Patient and public involvement
Patients were not invited to contribute to the writing or 
editing of this protocol for readability or accuracy. At this 
time, this systematic psychometric review will be done 
without patient involvement.
EthICS And dISSEMInAtIOn
Ethical approval and patient consent are not required as 
this is a review based on published studies. The review 
will be carried out using the best practices in system-
atic psychometric reviews.33–35 Results will be reported 
according to COSMIN and PRISMA) guidelines41 and 
will be disseminated at conferences and published in an 
international peer- reviewed journal.
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